Proteasome function is not impaired in healthy aging of the lung

Aging

Volumn 7, Issue 10, 2015, Pages 776-792

  Caniard, Anne ^a   Ballweg, Korbinian ^a   Lukas, Christina ^a   Yildirim, Ali Ö ^a   Eickelberg, Oliver ^a   Meiners, Silke ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Emphysema; Immunoproteasome; LMP2; Proteasome; Proteostasis

Indexed keywords

CYSTEINE PROTEINASE; LMP-2 PROTEIN; LMP7 PROTEIN; PROTEASOME; UBIQUITIN;

AGING; ANIMAL; C57BL MOUSE; DEFICIENCY; ENZYMOLOGY; FEMALE; KNOCKOUT MOUSE; LUNG; METABOLISM;

AGING; ANIMALS; CYSTEINE ENDOPEPTIDASES; FEMALE; LUNG; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITIN;

EID: 84946197831     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100820     Document Type: Article

References (58)

1. Meiners S, Eickelberg O, Konigshoff M. Hallmarks of the ageing lung. Eur. Respir. J. 2015;45:807-827.
2. Janssens JP, Pache JC, Nicod LP. Physiological changes in respiratory function associated with ageing. Eur. Respir. J. 1999;13:197-205.
3. Calvi CL, Podowski M, D'Alessio FR, Metzger SL, Misono K, Poonyagariyagorn H, et al. Critical Transition in Tissue Homeostasis Accompanies Murine Lung Senescence. Morty RE, editor. PLoS ONE. 2011;6:e20712.
4. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The Hallmarks of Aging. Cell. 2013;153:1194-1217.
5. Powers ET, Balch WE. Diversity in the origins of proteostasis networks-a driver for protein function in evolution. Nat. Rev. Mol. Cell Biol. 2013;14:237-248.
6. Tanaka K. The Proteasome: From Basic Mechanisms to Emerging Roles. Keio J. Med. 2013;62:1-12.
7. Finley D. Recognition and Processing of Ubiquitin-Protein Conjugates by the Proteasome. Annu. Rev. Biochem. 2009;78:477-513.
8. Meiners S, Keller IE, Semren N, Caniard A. Regulation of the Proteasome: Evaluating the Lung Proteasome as a New Therapeutic Target. Antioxid. Redox Signal. 2014;21:2364-82.
9. Groettrup M, Kirk CJ, Basler M. Proteasomes in immune cells: more than peptide producers? Nat. Rev. Immunol. 2010;10:73-78.
10. Aiken CT, Kaake RM, Wang X, Huang L. Oxidative stress-mediated regulation of proteasome complexes. Mol. Cell. Proteomics. 2011;10:R110.006924.
11. Nathan JA, Spinnenhirn V, Schmidtke G, Basler M, Groettrup M, Goldberg AL. Immuno-and Constitutive Proteasomes Do Not Differ in Their Abilities to Degrade Ubiquitinated Proteins. Cell. 2013;152:1184-1194.
12. Seifert U, Bialy LP, Ebstein F, Bech-Otschir D, Voigt A, Schröter F, et al. Immunoproteasomes Preserve Protein Homeostasis upon Interferon-Induced Oxidative Stress. Cell. 2010;142:613-624.
13. Ebstein F, Voigt A, Lange N, Warnatsch A, Schröter F, Prozorovski T, et al. Immunoproteasomes Are Important for Proteostasis in Immune Responses. Cell. 2013;152:935-937.
14. Keller JN, Hanni KB, Markesbery WR. Possible involvement of proteasome inhibition in aging: implications for oxidative stress. Mech. Ageing Dev. 2000;113:61-70.
15. Chondrogianni N, Sakellari M, Lefaki M, Papaevgeniou N, Gonos ES. Proteasome activation delays aging in vitro and in vivo. Free Radic. Biol. Med. 2014;71:303-320.
16. Vilchez D, Morantte I, Liu Z, Douglas PM, Merkwirth C, Rodrigues APC, et al. RPN-6 determines C. elegans longevity under proteotoxic stress conditions. Nature. 2012;489:263-268.
17. Chen Q, Thorpe J, Dohmen JR, Li F, Keller JN. Ump1 extends yeast lifespan and enhances viability during oxidative stress: central role for the proteasome? Free Radic. Biol. Med. 2006;40:120-126.
18. Tomaru U, Takahashi S, Ishizu A, Miyatake Y, Gohda A, Suzuki S, et al. Decreased Proteasomal Activity Causes Age-Related Phenotypes and Promotes the Development of Metabolic Abnormalities. Am. J. Pathol. 2012;180:963-972.
19. Tonoki A, Kuranaga E, Tomioka T, Hamazaki J, Murata S, Tanaka K, et al. Genetic Evidence Linking Age-Dependent Attenuation of the 26S Proteasome with the Aging Process. Mol. Cell. Biol. 2009;29:1095-1106.
20. Pickering AM, Lehr M, Miller RA. Lifespan of mice and primates correlates with immunoproteasome expression. J. Clin. Invest. 2015;125:2059-2068.
21. Keller IE, Vosyka O, Takenaka S, Kloß A, Dahlmann B, Willems LI, et al. Regulation of Immunoproteasome Function in the Lung. Sci. Rep. 2015;5:10230.
22. Schmidt M, Finley D. Regulation of proteasome activity in health and disease. Biochim. Biophys. Acta BBA-Mol. Cell Res. 2013; 1843:13-25.
23. Ferrington DA, Gregerson DS. Immunoproteasomes. Prog. Mol. Biol. Transl. Sci. Elsevier; 2012; 75-112.
24. Van Kaer L, Ashton-Rickardt PG, Eichelberger M, Gaczynska M, Nagashima K, Rock KL, et al. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity. 1994;1:533-541.
25. Goldman SJ, Chen E, Taylor R, Zhang S, Petrosky W, Reiss M, et al. Use of the ODD-Luciferase Transgene for the Non-Invasive Imaging of Spontaneous Tumors in Mice. PLoS ONE. 2011;6:e18269.
26. Kimbrel EA, Davis TN, Bradner JE, Kung AL. In vivo pharmacodynamic imaging of proteasome inhibition. Mol. Imaging. 2009;8:140-147.
27. Dahlmann B. Role of proteasomes in disease. BMC Biochem. 2007;8:S3.
28. Farout L, Friguet B. Proteasome function in aging and oxidative stress: implications in protein maintenance failure. Antioxid. Redox Signal. 2006;8:205-216.
29. Friguet B, Bulteau A-L, Conconi M, Petropoulos I. Redox Control of 20S Proteasome. Methods Enzymol. Elsevier; 2002; 253-262.
30. Breusing N, Arndt J, Voss P, Bresgen N, Wiswedel I, Gardemann A, et al. Inverse correlation of protein oxidation and proteasome activity in liver and lung. Mech. Ageing Dev. 2009;130:748-753.
31. Ding Q, Martin S, Dimayuga E, Bruce-Keller AJ, Keller JN. LMP2 knock-out mice have reduced proteasome activities and increased levels of oxidatively damaged proteins. Antioxid. Redox Signal. 2006;8:130-135.
32. Kisselev AF, Akopian TN, Castillo V, Goldberg AL. Proteasome Active Sites Allosterically Regulate Each Other, Suggesting a Cyclical Bite-Chew Mechanism for Protein Breakdown. Mol. Cell. 1999; 4:395-402.
33. Kisselev AF, Callard A, Goldberg AL. Importance of the Different Proteolytic Sites of the Proteasome and the Efficacy of Inhibitors Varies with the Protein Substrate. J. Biol. Chem. 2006;281:8582-8590.
34. Cook C, Gass J, Dunmore J, Tong J, Taylor J, Eriksen J, et al. Aging Is Not Associated with Proteasome Impairment in UPS Reporter Mice. PLoS ONE. 2009;4:e5888.
35. Giannini C, Kloß A, Gohlke S, Mishto M, Nicholson TP, Sheppard PW, et al. Poly-Ub-Substrate-Degradative Activity of 26S Proteasome Is Not Impaired in the Aging Rat Brain. PLoS ONE. 2013;8:e64042.
36. Ferrington DA. Altered proteasome structure, function, and oxidation in aged muscle. FASEB J. 2005;19:644-646.
37. Basler M, Kirk CJ, Groettrup M. The immunoproteasome in antigen processing and other immunological functions. Curr. Opin. Immunol. 2013;25:74-80.
38. Eleftheriadis T. The existence of two types of proteasome, the constitutive proteasome and the immunoproteasome, may serve as another layer of protection against autoimmunity. Med. Hypotheses. 2012;78:138-141.
39. Hasler P, Zouali M. Immune receptor signaling, aging, and autoimmunity. Cell. Immunol. 2005;233:102-108.
40. Stadtman ER. Protein oxidation and aging. Free Radic. Res. 2006;40:1250-1258.
41. De M, Jayarapu K, Elenich L, Monaco JJ, Colbert RA, Griffin TA. 2 Subunit Propeptides Influence Cooperative Proteasome Assembly. J. Biol. Chem. 2003;278:6153-6159.
42. Groettrup M, Standera S, Stohwasser R, Kloetzel PM. The subunits MECL-1 and LMP2 are mutually required for incorporation into the 20Sproteasome. Proc. Natl. Acad. Sci. 1997;94:8970-8975.
43. Hussong SA, Kapphahn RJ, Phillips SL, Maldonado M, Ferrington DA. Immunoproteasome deficiency alters retinal proteasome's response to stress. J. Neurochem. 2010; 113:1481-490.
44. Taraseviciene-Stewart L, Voelkel NF. Molecular pathogenesis of emphysema. J. Clin. Invest. 2008;118:394-402.
45. Tuder RM. Aging and Cigarette Smoke: Fueling the Fire. Am. J. Respir. Crit. Care Med. 2006;174:490-491.
46. Yamada Y, Tomaru U, Ishizu A, Ito T, Kiuchi T, Ono A, et al. Decreased proteasomal function accelerates cigarette smoke-induced pulmonary emphysema in mice. Lab. Invest. 2015; 95:625-634.
47. Andersson V, Hanzén S, Liu B, Molin M, Nyström T. Enhancing protein disaggregation restores proteasome activity in aged cells. Aging. 2013;5:802-812.
48. Walther DM, Kasturi P, Zheng M, Pinkert S, Vecchi G, Ciryam P, et al. Widespread Proteome Remodeling and Aggregation in Aging C. elegans. Cell. 2015;161:919-932.
49. Hipp MS, Patel CN, Bersuker K, Riley BE, Kaiser SE, Shaler TA, et al. Indirect inhibition of 26S proteasome activity in a cellular model of Huntington's disease. J. Cell Biol. 2012;196:573-587.
50. Bence NF, Sampat RM, Kopito RR. Impairment of the ubiquitin-proteasome system by protein aggregation. Science. 2001;292:1552-5.
51. Malhotra D, Thimmulappa R, Vij N, Navas-Acien A, Sussan T, Merali S, et al. Heightened Endoplasmic Reticulum Stress in the Lungs of Patients with Chronic Obstructive Pulmonary Disease: The Role of Nrf2-Regulated Proteasomal Activity. Am. J. Respir. Crit. Care Med. 2009;180:1196-1207.
52. van Rijt SH, Keller IE, John G, Kohse K, Yildirim AO, Eickelberg O, et al. Acute cigarette smoke exposure impairs proteasome function in the lung. Am. J. Physiol.-Lung Cell. Mol. Physiol. 2012;303:L814-823.
53. Min T, Bodas M, Mazur S, Vij N. Critical role of proteostasis-imbalance in pathogenesis of COPD and severe emphysema. J. Mol. Med. 2011;89:577-93.
54. Baker TA, Bach Iv HH, Gamelli RL, Love RB, Majetschak M. Proteasomes in lungs from organ donors and patients with end-stage pulmonary diseases. Physiol. Res. Acad. Sci. Bohemoslov. 2014;63:311-319.
55. Fehling HJ, Swat W, Laplace C, Kühn R, Rajewsky K, Müller U, et al. MHC class I expression in mice lacking the proteasome subunit LMP-7. Science. 1994;265:1234-1237.
56. Safran M, Kim WY, O'Connell F, Flippin L, Gunzler V, Horner JW, et al. Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: Assessment of an oral agent that stimulates erythropoietin production. Proc. Natl. Acad. Sci. 2006;103:105-110.
57. Hernebring M, Fredriksson Å, Liljevald M, Cvijovic M, Norrman K, Wiseman J, et al. Removal of damaged proteins during ES cell fate specification requires the proteasome activator PA28. Sci. Rep. 2013;3:1381.
58. Walther DM and Mann M. Accurate Quantification of More Than 4000 Mouse Tissue Proteins Reveals Minimal Proteome Changes During Aging. Molecular & Cellular Proteomics. 2011;10:M110.004523-M110.004523.